Approval · Notice of Compliance 34976 · 2025
TELMISARTAN: Notice of Compliance 34976
Issued March 7, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34976
- Date
- March 7, 2025
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
- Canadian reference product
- MICARDIS (Boehringer Ingelheim (Canada) Ltd.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TELMISARTAN | 02390345 | Marketed |
| TELMISARTAN | 02390353 | Marketed |
Medicinal ingredients
- TELMISARTAN 40 MG per TAB
- TELMISARTAN 80 MG per TAB